Sun Pharma Canada Launches (PR)WINLEVI® (clascoterone cream 1% w/w), a Novel Topical Treatment for Acne
WINLEVI (clascoterone cream 1% w/w) for male and female acne patients 12 years of age and older is now available in Canada.
- WINLEVI (clascoterone cream 1% w/w) for male and female acne patients 12 years of age and older is now available in Canada.
- WINLEVI is the first and only topical Androgen Receptor Inhibitor, and the newest Health Canada-approved formulation to target the hormonal component of acne in 40 years.
- WINLEVI is the first and only androgen receptor inhibitor indicated for the topical treatment of acne vulgaris (acne) in patients 12 years of age and older.
- WINLEVI works differently from any other topical acne treatment.